Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. (opens new window)

Arbach O, Funck R, Seibt F, Salama A.

Źródło‎: Transfus Med Hemother 2012;39(3):221-3.

Indeks‎: PubMed 22851939

DOI‎: 10.1159/000339260

https://www.ncbi.nlm.nih.gov/pubmed/22851939 (opens new window)

The changing spectrum of drug-induced immune hemolytic anemia. (opens new window)

Arndt PA, Garratty G.

Źródło‎: Semin Hematol 2005;42(3):137-44.

Indeks‎: PubMed 16041663

https://www.ncbi.nlm.nih.gov/pubmed/16041663 (opens new window)

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. (opens new window)

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Fanin R, Zanella A.

Źródło‎: Blood 2012;119(16):3691-7.

Indeks‎: PubMed 22267606

DOI‎: 10.1182/blood-2011-06-363556

https://www.ncbi.nlm.nih.gov/pubmed/22267606 (opens new window)

Autoimmune hemolytic anemia. (opens new window)

Gehrs BC, Friedberg RC.

Źródło‎: Am J Hematol 2002;69(4):258-71.

Indeks‎: PubMed 11921020

https://www.ncbi.nlm.nih.gov/pubmed/11921020 (opens new window)

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias. (opens new window)

Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC.

Źródło‎: Blood 2010;116(23):4783-5.

Indeks‎: PubMed 20841509

DOI‎: 10.1182/blood-2010-06-291831

https://www.ncbi.nlm.nih.gov/pubmed/20841509 (opens new window)

A case of late-onset systemic lupus erythematosus with severe anemia. (opens new window)

Matsumoto M, Kaieda S, Honda S, Ida H, Hoshino T, Fukuda T.

Źródło‎: Kurume Med J 2013;60(1):25-8.

Indeks‎: PubMed 23925156

https://www.ncbi.nlm.nih.gov/pubmed/23925156 (opens new window)

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. (opens new window)

Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA.

Źródło‎: Blood 2002;100(2):704-6.

Indeks‎: PubMed 12091370

DOI‎: 10.1182/blood-2002-01-0087

https://www.ncbi.nlm.nih.gov/pubmed/12091370 (opens new window)

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. (opens new window)

Zecca M, De Stefano P, Nobili B, Locatelli F.

Źródło‎: Blood 2001;97(12):3995-7.

Indeks‎: PubMed 11389047

https://www.ncbi.nlm.nih.gov/pubmed/11389047 (opens new window)

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. (opens new window)

Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, Jankovic M, Pierani P, De Stefano P, Bonora MR, Locatelli F.

Źródło‎: Blood 2003;101(10):3857-61.

Indeks‎: PubMed 12531800

DOI‎: 10.1182/blood-2002-11-3547

https://www.ncbi.nlm.nih.gov/pubmed/12531800 (opens new window)